BSX - Boston Scientific Corporation

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue9,048,0008,386,0007,477,000
Cost of Revenue2,593,0002,424,0002,173,000
Gross Profit6,455,0005,962,0005,304,000
Operating Expenses
Research Development997,000920,000876,000
Selling General and Administrative3,214,0003,128,0002,996,000
Non Recurring394,000922,0001,220,000
Others565,000545,000495,000
Total Operating Expenses5,170,0005,515,0005,587,000
Operating Income or Loss1,285,000447,000-283,000
Income from Continuing Operations
Total Other Income/Expenses Net-124,000-37,000-83,000
Earnings Before Interest and Taxes1,162,000410,000-366,000
Interest Expense229,000233,000284,000
Income Before Tax933,000177,000-650,000
Income Tax Expense828,000-170,000-411,000
Minority Interest---
Net Income From Continuing Ops105,000347,000-239,000
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income104,000347,000-239,000
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares104,000347,000-239,000